Cerity Partners’s Eastman Chemical EMN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.66M | Sell |
84,572
-69,755
| -45% | -$5.1M | 0.01% | 1039 |
|
|
2026
Q1 | $11.8M | Sell |
154,327
-102,715
| -40% | -$7.4M | 0.02% | 621 |
|
|
2025
Q4 | $16.4M | Buy |
257,042
+18,934
| +8% | +$1.17M | 0.02% | 470 |
|
|
2025
Q3 | $15M | Sell |
238,108
-52,243
| -18% | -$3.65M | 0.02% | 449 |
|
|
2025
Q2 | $21.7M | Buy |
290,351
+73,332
| +34% | +$5.76M | 0.04% | 344 |
|
|
2025
Q1 | $19.1M | Buy |
217,019
+2,920
| +1% | +$276K | 0.04% | 344 |
|
|
2024
Q4 | $19.7M | Sell |
214,099
-2,259
| -1% | -$232K | 0.04% | 316 |
|
|
2024
Q3 | $24.2M | Buy |
216,358
+3,624
| +2% | +$363K | 0.05% | 281 |
|
|
2024
Q2 | $20.8M | Sell |
212,734
-2,858
| -1% | -$284K | 0.05% | 274 |
|
|
2024
Q1 | $21.8M | Buy |
215,592
+8,850
| +4% | +$778K | 0.06% | 278 |
|
|
2023
Q4 | $18.7M | Buy |
206,742
+8,098
| +4% | +$645K | 0.06% | 254 |
|
|
2023
Q3 | $15.4M | Sell |
198,644
-2,214
| -1% | -$184K | 0.07% | 232 |
|
|
2023
Q2 | $17M | Sell |
200,858
-1,749
| -0.9% | -$142K | 0.07% | 257 |
|
|
2023
Q1 | $16.9M | Buy |
202,607
+6,234
| +3% | +$535K | 0.04% | 265 |
|
|
2022
Q4 | $16.1M | Buy |
196,373
+8,452
| +4% | +$681K | 0.1% | 195 |
|
|
2022
Q3 | $13.5M | Sell |
187,921
-6,924
| -4% | -$622K | 0.16% | 125 |
|
|
2022
Q2 | $17.6M | Buy |
194,845
+192,574
| +8,480% | +$19.9M | 0.2% | 111 |
|
|
2022
Q1 | $255K | Sell |
2,271
-186
| -8% | -$21.8K | ﹤0.01% | 789 |
|
|
2021
Q4 | $296K | Buy |
+2,457
| New | +$273K | ﹤0.01% | 772 |
|
|
2019
Q4 | – | Sell |
-12,792
| Closed | -$945K | – | 544 |
|
|
2019
Q3 | $945K | Buy |
12,792
+10,028
| +363% | +$720K | 0.06% | 255 |
|
|
2019
Q2 | $215K | Sell |
2,764
-2,443
| -47% | -$186K | 0.01% | 443 |
|
|
2019
Q1 | $395K | Sell |
5,207
-9,527
| -65% | -$757K | 0.03% | 367 |
|
|
2018
Q4 | $1.08M | Sell |
14,734
-3,226
| -18% | -$257K | 0.07% | 215 |
|
|
2018
Q3 | $1.72M | Sell |
17,960
-137
| -0.8% | -$13.6K | 0.12% | 184 |
|
|
2018
Q2 | $1.81M | Buy |
18,097
+2,385
| +15% | +$252K | 0.13% | 167 |
|
|
2018
Q1 | $1.66M | Buy |
15,712
+4,640
| +42% | +$469K | 0.13% | 168 |
|
|
2017
Q4 | $1.03M | Buy |
11,072
+3,270
| +42% | +$297K | 0.07% | 236 |
|
|
2017
Q3 | $706K | Sell |
7,802
-103,627
| -93% | -$8.82M | 0.05% | 275 |
|
|
2017
Q2 | $1.57M | Buy |
+111,429
| New | +$8.98M | 0.13% | 141 |
|
Other funds holding EMN
Cerity Partners's EMN Position: Q2 2026 in Review
Cerity Partners reduced its Eastman Chemical (EMN) stake by 45% in Q2 2026, selling an estimated $5.1M and leaving 84,572 shares worth $5.66M. The position accounts for 0.01% of the portfolio, ranked #1039.
Cerity Partners first reported a position in EMN in Q2 2017 and has held it in 29 quarters since. The position peaked at $24.2M in Q3 2024. 644 funds tracked by Wall St. Rank hold EMN as of Q2 2026.
- Cerity Partners held 84,572 shares of Eastman Chemical worth $5.66M as of Q2 2026.
- Cerity Partners sold 69,755 Eastman Chemical shares in Q2 2026, an estimated $5.1M.
- Eastman Chemical made up 0.01% of Cerity Partners's portfolio in Q2 2026, its #1039 holding.
- Cerity Partners first reported a position in Eastman Chemical in Q2 2017 and has held it in 29 quarters since.
- Cerity Partners's Eastman Chemical position peaked at $24.2M in Q3 2024.
- 644 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.
Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.